Literature DB >> 27885872

Improvement of solubility, dissolution and stability profile of artemether solid dispersions and self emulsified solid dispersions by solvent evaporation method.

Muhammad Tayyab Ansari1, Muhammad Sohail Arshad1, Altaf Hussain1, Zeeshan Ahmad2.   

Abstract

The purpose of this study was to investigate changes in the water solubility of artemether; a poorly soluble drug used for the treatment of malaria. Different solid dispersions (SDs) of artemether were prepared using artemether and polyethylene glycol 6000 at ratio 12:88 (Group 1), self-emulsified solid dispersions (SESDs) containing artemether, polyethylene glycol 6000, cremophor-A-25, olive oil, hydroxypropylmethylcellulose and transcutol in the ratio 12:75:5:4:2:2, respectively (Group 2). SESDs were also prepared by substituting cremophor-A-25 in Group 2 with poloxamer 188 (noted as Group 3). Each of these preparations was formulated using physical mixing and the solvent evaporation method. Aqueous solubility of artemether improved 11-, 95- and 102-fold, while dissolution (in simulated gastric fluid) increased 3-, 13- and 14-fold, for formulation groups 1, 2 and 3, respectively. X-ray diffraction patterns of SDs indicated a decrease in peak intensities at 10° implying reduced artemether crystallinity. Scanning electron micrographs invariably revealed embedment of artemether by various excipients and a glassy appearance for solvent evaporated mixtures for all three formulation Groups. Our findings indicate improved hydrophilic interactions for drug particles yield greater solubility and dissolution in the following order for artemether formulating methods: solvent evaporation mixtures > physical mixtures > pure artemether.

Entities:  

Keywords:  Artemether; dissolution; self-emulsified solid dispersions; solid dispersions; solubility; stability

Mesh:

Substances:

Year:  2016        PMID: 27885872     DOI: 10.1080/10837450.2016.1265554

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  2 in total

1.  A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier.

Authors:  Hiroyuki Takabe; Zachary N Warnken; Yajie Zhang; Daniel A Davis; Hugh D C Smyth; John G Kuhn; Steve Weitman; Robert O Williams Iii
Journal:  Pharmaceutics       Date:  2018-05-19       Impact factor: 6.321

Review 2.  Nanobiotechnological modules as molecular target tracker for the treatment and prevention of malaria: options and opportunity.

Authors:  Jain Anamika; Vishwakarma Nikhar; Gautam Laxmikant; Shrivastava Priya; Vyas Sonal; S P Vyas
Journal:  Drug Deliv Transl Res       Date:  2020-08       Impact factor: 4.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.